Medigene Stock Forecast for 2023 - 2025 - 2030
Updated on 05/05/2024
Medigene Stock Forecast and Price Target
If the average 2024 price target of 2.68€ recently set by prominent experts for Medigene is met, there would be a potential upside of approximately 72.9% from the last closing price in May, 2024. The high estimate is 3.00€, and the low is 2.35€. Even if you are not interested in MDG1 stock, you should be aware of its competitors and their current standings.
72.90% Upside
Medigene Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Medigene's Price has seen an increase, rising from 0.00€ to 0.00€. This represents a growth of 100.00%. Analysts predict that Medigene's Fair Value will increase in the upcoming year, reaching 1.63€. This would represent an increase of 100.00%. Over the next seven years, experts predict that Medigene's Fair Value will grow at a rate of 100.00%.
Medigene Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Medigene's Revenue has seen an increase, rising from 8.00€M to 31.25€M. This represents a growth of 290.63%. In the following year, 2 experts forecast Medigene's Revenue will decrease by 63.20%, to 11.50€M. In 2030, professionals predict that Medigene's Revenue will decrease by 24.48%, to 23.60€M.
Medigene EBITDA Forecast for 2023 - 2025 - 2030
Medigene's EBITDA has grown in the last two years, jumping from -23.82€M to 32.77€M – an increase of 237.57%. According to 2 analysts, Medigene's EBITDA will fall by 133.38% in the next year, reaching -10.94€M. Professionals believe that By 2030, Medigene's EBITDA will fall to -26.73€M – a 181.57% decrease from its current value.
Medigene EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Medigene's EBIT has increased by 142.94%, going from -27.20€M to 11.68€M. In the following year, 2 experts forecast that Medigene's EBIT will decrease by 201.46%, to -11.85€M. In 2030, professionals predict that Medigene's EBIT will decrease by 345.72%, to -28.70€M.
Medigene EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Medigene's EPS has seen an increase, rising from -1.18€ to 0.00€. This represents a growth of 100.00%. Analysts predict that Medigene's EPS will increase in the upcoming year, reaching -0.40€. This would represent an increase of 100.00%. Over the next seven years, experts predict that Medigene's EPS will grow at a rate of 100.00%.